An observational study in Severe Acute Malnutrition, sponsored by Epicentre. Completed. Open to participants aged 6 Months to 59 Months. Per ClinicalTrials.gov, last updated 2018-02-05.
Sponsored by Epicentre · Observational
Retrospective analysis of routine program data of children aged 6 to 59 months admitted to the MSF therapeutic feeding program with MUAC ≤ 118 mm in Yako and Titao districts of Burkina Faso from 2007-2011.
Comparison of patient characteristics and treatment outcomes was conducted between two groups: 1) children discharged as recovered from September 2007 to March 2009 with at least 15% of their weight at admission (Period A); and 2) children discharged as recovered from April 2009 to December 2011 with MUAC ≥ 124 mm (Period B).
A total of 50,841 children were admitted with MUAC ≤ 118 mm to the MSF therapeutic feeding program and were included in this analysis: 24,792 children in Period A (2007-2009) and 26,049 children in Period B (2009-2011).
Overall, 89% of admissions were directly into outpatient care and the majority (53%) entered with a MUAC 116-118mm; 48% of children were male and 80% of children \< 2 years of age (Table 1).
Compared to children admitted in Period A, children admitted in Period B were statistically more likely to be female, younger, and of better anthropometric status (e.g. higher mean MUAC, WHZ and HAZ).
There was a greater proportion of children admitted directly to inpatient care in Period B than in Period A (10.6% vs 8.0%).
All children admitted to the MSF therapeutic feeding program in Yako and Titao districts from September 2007 to December 2011
Exclusion Criteria:
Children discharged as recovered from September 2007 to March 2009 with at least 15% of their weight at admission
Other: Discharge from community-based management
Children discharged as recovered from April 2009 to December 2011 with Children discharged as recovered from September 2007-March 2009 with MUAC ≥ 124 mm
Other: Discharge from community-based management
Comparison of patient characteristics and treatment outcomes between two groups
MUAC based criterion
Use of a discharge criterion of MUAC ≥ 124 mm
Time frame: 52 months
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Jan 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Epicentre